BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27320335)

  • 21. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
    Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
    J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
    le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
    J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RXR: from partnership to leadership in metabolic regulations.
    Desvergne B
    Vitam Horm; 2007; 75():1-32. PubMed ID: 17368310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
    Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver.
    Lalloyer F; Pedersen TA; Gross B; Lestavel S; Yous S; Vallez E; Gustafsson JA; Mandrup S; Fiévet C; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1488-95. PubMed ID: 19592467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
    le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
    Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.
    Sharma S; Shen T; Chitranshi N; Gupta V; Basavarajappa D; Sarkar S; Mirzaei M; You Y; Krezel W; Graham SL; Gupta V
    Mol Neurobiol; 2022 Apr; 59(4):2027-2050. PubMed ID: 35015251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
    Sanchez PV; Glantz ST; Scotland S; Kasner MT; Carroll M
    Leukemia; 2014 Apr; 28(4):749-60. PubMed ID: 23823656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.
    Westin S; Kurokawa R; Nolte RT; Wisely GB; McInerney EM; Rose DW; Milburn MV; Rosenfeld MG; Glass CK
    Nature; 1998 Sep; 395(6698):199-202. PubMed ID: 9744281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multi-faceted role of retinoid X receptor in bone remodeling.
    Menéndez-Gutiérrez MP; Ricote M
    Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative retinoid X receptor (RXR) ligands.
    Krężel W; Rühl R; de Lera AR
    Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
    Schierle S; Merk D
    Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
    [No Abstract]   [Full Text] [Related]  

  • 34. Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.
    Pettersson F; Hanna N; Lagodich M; Dupéré-Richer D; Couture MC; Choi C; Miller WH
    J Biol Chem; 2008 Aug; 283(32):21945-52. PubMed ID: 18544536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD; Walfish PG; DeLuca H; Butt TR
    Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification.
    Simandi Z; Horvath A; Cuaranta-Monroy I; Sauer S; Deleuze JF; Nagy L
    Mol Cell Endocrinol; 2018 Aug; 471():51-62. PubMed ID: 28778663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterodimerization among thyroid hormone receptor, retinoic acid receptor, retinoid X receptor, chicken ovalbumin upstream promoter transcription factor, and an endogenous liver protein.
    Berrodin TJ; Marks MS; Ozato K; Linney E; Lazar MA
    Mol Endocrinol; 1992 Sep; 6(9):1468-78. PubMed ID: 1331778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of Bexarotene Analogs for Treating Cutaneous T-Cell Lymphomas.
    Warda A; Staniszewski LJP; Sabir Z; Livingston S; Sausedo M; Reshi S; Ron E; Applegate MT; Haddad D; Khamisi M; Marshall PA; Wagner CE; Jurutka PW
    Cells; 2023 Nov; 12(21):. PubMed ID: 37947652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification at the acidic domain of RXR agonists has little effect on permissive RXR-heterodimer activation.
    Fujii S; Ohsawa F; Yamada S; Shinozaki R; Fukai R; Makishima M; Enomoto S; Tai A; Kakuta H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5139-42. PubMed ID: 20656484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.